Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Becton Dickinson
(NY:
BDX
)
229.11
+4.17 (+1.85%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Becton Dickinson
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Stocks To Buy For Consistent Dividend Growth
March 11, 2023
One way to avoid some of the volatility in the stock market is to buy old companies that have a long history of raising dividends. These are companies with iconic brands, lasting products, and...
Via
Talk Markets
Becton, Dickinson's Debt Overview
March 10, 2023
Via
Benzinga
(BDX) - Analyzing Becton, Dickinson's Short Interest
March 09, 2023
Via
Benzinga
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
By David Willey, Benzinga
Via
TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via
News Direct
Looking Into Becton's Return On Capital Employed
February 03, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Becton, Dickinson
February 03, 2023
Via
Benzinga
A Bullish Sign Appears On Becton, Dickinson's Chart
January 24, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Becton, Dickinson
January 06, 2023
Via
Benzinga
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices.
Via
Benzinga
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
March 01, 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via
MarketBeat
Topics
Initial Public Offering
Exposures
COVID-19
Product Safety
Securities Market
The 7 Best Dividend Growth Stocks for Long-Term Investors
February 22, 2023
Although passive income is always useful under uncertain times, why not get capital gains through the best dividend growth stocks?
Via
InvestorPlace
Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software
February 17, 2023
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software.
Via
Benzinga
2 Medical Stocks to Watch Heading Into 2023
December 31, 2022
The two healthcare companies easily outdid the S&P 500 this year.
Via
The Motley Fool
Embecta Stock Tumbles On Mixed Q4 Results, Softer Guidance
December 20, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About Becton, Dickinson
December 12, 2022
Via
Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
February 15, 2023
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in...
Via
Benzinga
Why Embecta Stock Popped by Nearly 13% Today
February 14, 2023
Twin beats and raised guidance make for a good day on the market for the diabetes care specialist.
Via
The Motley Fool
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
By David Willey, Benzinga
Via
TheNewswire.com
Topics
Economy
Exposures
Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via
News Direct
Topics
Economy
Exposures
Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the...
Via
Benzinga
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
January 12, 2023
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Becton Dickinson, Freeport-McMoRan, GXO Logistics And This Mid-Cap ETF On CNBC's 'Final Trades'
January 10, 2023
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named iShares Core S&P Mid-Cap ETF (NYSE: IJH), saying that "mid-c
Via
Benzinga
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
January 09, 2023
Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development...
Via
Benzinga
2 Relatively Safe Dividend Stocks to Buy Today and Hold Forever
January 02, 2023
They already have extensive track records of success, and there's even more on the way.
Via
The Motley Fool
2 Top Dividend Kings to Buy for the Long Haul
December 14, 2022
No matter how much changes, these two healthcare giants keep performing.
Via
The Motley Fool
Reliable Passive Income: an Analysis on Dividend Kings
December 13, 2022
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
NIO To $34? Plus This Analyst Sees $245 For Becton, Dickinson and Company
November 11, 2022
Piper Sandler cut the price target on Becton, Dickinson and Company (NYSE: BDX) from $255 to $245. Piper Sandler analyst Jason Bednar maintained the stock with a Neutral. Becton, Dickinson shares...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit